Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals Shares Homepage, Bse Sensex,NSE Nifty,Latest Prices,Live News,Gainers Losersd,Top Performer,Market Commentry,Live Quotes,Bulk Deals
myirislogo
23 November, 2024 13:46 IST
Earnings
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Yes Bank 24.08 42.49
Tata Stl 136.10 30.24
Ong Corp 255.50 95.26
I T C Lt 439.00 28.72
Ntpc Ltd 318.20 88.67
Clear All Clear Last
Equity
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
Market Pulse
Leaders
Laggards
FII Activity
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Quotes
Charts
Financials
Recent News
Broker Research
Research
Research Reports
Lasa Supergenerics Limited
Pharmaceuticals - Pharmaceuticals - Others
BSE:540702NSE:LASABloomberg:LASA@INReuters:LASA.BO
Market Lot: 1Face Value: 10ISIN Demat: INE670X01014
QuotesChartsFinancialsResearchRecent News
MF HoldingBSE/NSE Notices

Company Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 16-JAN-24
Closure of Trading Window 30-DEC-23
Disclosure Of Related Party Transaction Under Regulation 23(9) Of SEBI (Listing Obligation And Disclosure Requirement) Regulation, 2015 10-NOV-23
Board Meeting Intimation for Unaudited Financial Results Of The Company For Q2 04-NOV-23
Material Event Update In Compliance With Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, 10-OCT-23
Closure of Trading Window 29-SEP-23
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 28-SEP-23
Shareholder Meeting / Postal Ballot-Outcome of AGM 28-SEP-23
Announcement under Regulation 30 (LODR)-Newspaper Publication 06-SEP-23
Reg. 34 (1) Annual Report. 04-SEP-23
Outcome Of Board Meeting Held Today I.E. September 02, 2023 02-SEP-23
Board Meeting Outcome for Outcome Of Board Meeting 14-AUG-23

© All rights reserved. IRIS Business Services Limited
Disclaimer